Lv2
168 积分 2026-01-18 加入
Prevalence of Hidradenitis Suppurativa in Xi’an, China: A Single Center Epidemiological Study
2天前
已完结
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis
2个月前
已完结
Long-term efficacy of biologics in moderate-to-severe hidradenitis suppurativa: A systematic review and MAIC
2个月前
已完结
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis
4个月前
已完结
Long‐term efficacy of biologics in moderate‐to‐severe hidradenitis suppurativa: A systematic review and MAIC
4个月前
已完结
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis
4个月前
已完结
Bimekizumab long-term response in psoriasis: Mechanistic insights into efficacy level and durability
5个月前
已完结
Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial
5个月前
已完结
Bimekizumab versus Secukinumab in Plaque Psoriasis
5个月前
已完结
Bimekizumab versus Adalimumab in Plaque Psoriasis
5个月前
已完结
皖公网安备34019202002308
